Reset

Advanced Filters
06:45pm - 07:45pm EDT - October 27, 2018

Saturday
Evaluating urology-specific clinical competency of a professional urology nurse is a continuing process. The use of uniquely developed competency assessment tools are discussed. These proficiencies have proven to be very valuable in our urology practice and have become an essential part of our nurse’s annual performance appraisals. Experience with this competency protocol, our rating system, validation, and evaluation practice for each of our specific competencies are shared.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this continuing nursing education activity the learner will be able to identify new resources for urology nurse compentencies in an outpatient practice.

Saturday
Nocturia, defined as interruption of sleep owing to a desire to urinate, is one of the most common and most bothersome lower urinary tract symptoms. This lecture reviews the epidemiology, pathophysiology, evaluation and management of nocturia focusing on urologic specialty and advanced practice.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure:
Mikel Gray, PhD, FNP, PNP, CUNP, CCCN, FAANP, FAAN
Consultant - Laborie Medical

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
At the conclusion of this activity, the learner will be able to identify bothersome nocturia, assess contributing factors, and propose strategies to manage this prevalent lower urinary tract symptom.

Saturday
The participants of this lecture will understand the evidence behind physical therapy diagnosis and treatment for pelvic floor disorders and understand the components of pelvic floor physical therapy evaluation and treatment. Clinicians will learn how to do a basic pelvic floor examination and suggestions will be made about how to work within an interdisciplinary treatment model. Diagnoses covered will include vulvodynia, interstitial cystitis, pudendal neuralgia, CPPS and stress urinary incontinence and pelvic organ prolapse.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this continuing nursing education activity the learner will be able to explain evaluation and treatment for patients with pelvic pain.

Saturday
06:45pm - 07:45pm EDT - October 27, 2018 | Room: Grande Ballroom B
Credits Available:
1.00 CH | 0.50 Rx
After decades without significant advances in bladder cancer treatment, numerous new agents that help to reactivate the patient’s own antitumor response have been approved. This presentation covers bladder cancer from NMIBC, MIBC to metastatic bladder cancer incorporating intravesical treatments, new therapies, relevant guidelines and evidence-based therapies. It is important to understand the pathophysiology of bladder cancer, long-term sequalae, and the rationale for the various therapies.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure: There are no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this continuing nursing education activity the learner will be able to identify and incorporate new treatments for bladder cancer.